Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study

Table 10 Modified Ashworth Score left values of each patient

	Modified Ashworth Score (left)
	Pre-test	Post-test (1st wk)	Post-test (1st month)	Post-test (2nd month)	Post-test (4th month)	Post-test (12th month)
Patient 1	19	19	16	16	14	12
Patient 2	20	20	15	14	13	13
Patient 3	20	20	18	17	16	11
Patient 4	23	23	21	21	19	19
Patient 5	9	9	8	7	7	6
Patient 6	22	20	20	20	17	17